ARHGDIG and pancreatic neoplasm: For the first time, we reported the different subcellular expression patterns and activation state of RhoGDI3 protein as well as the expression of two Rho GTPases, RhoG and RhoB, documented as target molecules for this negative regulator, in normal and cancerous human pancreatic cancer cell lines and human pancreatic tissue.